The four new methodological Patient-Focused Drug Development guidance documents the FDA is currently developing for the industry that incorporate patient experience data into drug development, summarized.
Nadeeka R. Dias, PhD
Advertisement
Articles by Nadeeka R. Dias, PhD
Advertisement
Latest Updated Articles
FDA Patient-Focused Drug Development Guidance Update: Incorporating Patient Experience Data in Clinical TrialsPublished: May 28th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Enhancing Data Quality and Real-World Evidence in Clinical Research
3
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
